XML 24 R13.htm IDEA: XBRL DOCUMENT v3.21.2
Note 5 - Goodwill and Intangible Assets, Net
6 Months Ended
Sep. 30, 2021
Notes to Financial Statements  
Goodwill and Intangible Assets Disclosure [Text Block]

Note 5. Goodwill and Intangible Assets, Net

 

Finite-lived intangible assets consist of the following:

 

  

September 30, 2021

  

March 31, 2021

 
  

Gross Carrying Amount

  

Accumulated Amortization

  

Net Carrying Amount

  

Gross Carrying Amount

  

Accumulated Amortization

  

Net Carrying Amount

 

Intellectual property

 $21,094  $(9,409) $11,685  $21,201  $(8,595) $12,606 

Trade names

  8,574   (3,265)  5,309   8,612   (3,129)  5,483 

Customer relationships

  144,869   (58,459)  86,410   145,754   (52,206)  93,548 

Non-compete agreements

  1,299   (1,215)  84   1,299   (1,195)  104 

Total

 $175,836  $(72,348) $103,488  $176,866  $(65,125) $111,741 

 

Amortization expense for finite-lived intangible assets acquired in a business combination was $3,757 and $7,573 for the three and six months ended September 30, 2021, respectively, and $3,512 and $6,866 for the three and six months ended September 30, 2020, respectively. During the quarter ended June 30, 2020, we reduced the value of our intangible assets due to a purchase price adjustment that resulted in a cumulative effect net decrease to amortization expense of $334. 

 

For the following fiscal years ending March 31, amortization expense is estimated as follows:

 

Remainder of 2022

  7,398 

2023

  14,622 

2024

  14,107 

2025

  12,515 

2026

  11,731 

 

The change in the carrying amount of goodwill was as follows:

 

  

Sterilization and Disinfection Control

  

Biopharmaceutical Development

  

Instruments

  

Continuous Monitoring

  

Total

 

March 31, 2021

 $30,153  $93,399  $19,186  $18,103  $160,841 

Effect of foreign currency translation

  (100)  (752)  (12)  -   (864)

September 30, 2021

 $30,053  $92,647  $19,174  $18,103  $159,977